Autopsy report · NCT01522170

aHUS Observational Long Term Follow-Up

“Remaining patients were offered a similar observational study (Alexion M11-001) to allow for robust, high quality data collection in a larger, single database”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 4 years 10 months before it stopped.
• 94 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Alexion Pharmaceuticals, Inc.

Sponsor type

Industry

Conditions

Atypical Hemolytic Uremic Syndrome

Participants

94

Sites

56

Countries

Australia, Austria, Belgium, Canada, France, Germany, Italy, Netherlands, Sweden, Switzerland, United Kingdom, United States

Trials that died the same way

• Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy
  “So far, we have not been able to collect meaningful data for these patients which also led to our decision to close this study before attempting write up and publish any results” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.